HK1209646A1 - Nasal influenza vaccine composition - Google Patents
Nasal influenza vaccine compositionInfo
- Publication number
- HK1209646A1 HK1209646A1 HK15110594.2A HK15110594A HK1209646A1 HK 1209646 A1 HK1209646 A1 HK 1209646A1 HK 15110594 A HK15110594 A HK 15110594A HK 1209646 A1 HK1209646 A1 HK 1209646A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- vaccine composition
- influenza vaccine
- nasal influenza
- nasal
- composition
- Prior art date
Links
- 229960003971 influenza vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012287900 | 2012-12-28 | ||
| PCT/JP2013/078721 WO2014103488A1 (ja) | 2012-12-28 | 2013-10-23 | 経鼻インフルエンザワクチン組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1209646A1 true HK1209646A1 (en) | 2016-04-08 |
Family
ID=51020588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15110594.2A HK1209646A1 (en) | 2012-12-28 | 2015-10-28 | Nasal influenza vaccine composition |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US20160015800A1 (ja) |
| EP (2) | EP3566715A1 (ja) |
| JP (1) | JP6247639B2 (ja) |
| KR (1) | KR102071099B1 (ja) |
| CN (2) | CN104884086A (ja) |
| AU (1) | AU2013367751B2 (ja) |
| BR (1) | BR112015015523B1 (ja) |
| CA (1) | CA2894223C (ja) |
| CY (1) | CY1122372T1 (ja) |
| DK (1) | DK2939692T3 (ja) |
| ES (1) | ES2731899T3 (ja) |
| HK (1) | HK1209646A1 (ja) |
| HU (1) | HUE044434T2 (ja) |
| IL (1) | IL239284B (ja) |
| LT (1) | LT2939692T (ja) |
| MX (1) | MX371154B (ja) |
| MY (1) | MY173503A (ja) |
| NZ (1) | NZ708922A (ja) |
| PH (1) | PH12015501482A1 (ja) |
| PL (1) | PL2939692T3 (ja) |
| PT (1) | PT2939692T (ja) |
| RU (1) | RU2652296C2 (ja) |
| SG (2) | SG10201705190TA (ja) |
| SI (1) | SI2939692T1 (ja) |
| TR (1) | TR201910293T4 (ja) |
| TW (1) | TWI624280B (ja) |
| WO (1) | WO2014103488A1 (ja) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2588183T3 (es) * | 2009-03-31 | 2016-10-31 | Japan As Represented By Director-General Of National Institute Of Infectious Diseases | Procedimiento para la prevención de la gripe utilizando una vacuna para administración intranasal |
| US9457077B2 (en) | 2009-11-18 | 2016-10-04 | Katherine Rose Kovarik | Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases |
| US9408880B2 (en) | 2013-12-20 | 2016-08-09 | Katherine Rose Kovarik | Method and system for prevention and treatment of allergic and inflammatory diseases |
| US9585920B2 (en) | 2011-02-04 | 2017-03-07 | Katherine Rose Kovarik | Method and system for treating cancer cachexia |
| US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
| US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
| US9730967B2 (en) | 2011-02-04 | 2017-08-15 | Katherine Rose Kovarik | Method and system for treating cancer cachexia |
| US11998479B2 (en) | 2011-02-04 | 2024-06-04 | Seed Health, Inc. | Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure |
| US10314865B2 (en) | 2011-02-04 | 2019-06-11 | Katherine Rose Kovarik | Method and system for treating cancer and other age-related diseases by extending the healthspan of a human |
| US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
| US11998574B2 (en) | 2013-12-20 | 2024-06-04 | Seed Health, Inc. | Method and system for modulating an individual's skin microbiome |
| US11980643B2 (en) | 2013-12-20 | 2024-05-14 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
| US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
| US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
| US12005085B2 (en) | 2013-12-20 | 2024-06-11 | Seed Health, Inc. | Probiotic method and composition for maintaining a healthy vaginal microbiome |
| US11969445B2 (en) | 2013-12-20 | 2024-04-30 | Seed Health, Inc. | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH |
| US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
| JP6322844B2 (ja) | 2014-06-25 | 2018-05-16 | 東興薬品工業株式会社 | 医療用シリンジに用いられる点鼻用噴霧ノズル |
| WO2015199129A1 (ja) | 2014-06-25 | 2015-12-30 | 東興薬品工業株式会社 | インフルエンザワクチン経鼻接種システム |
| CN105342982B (zh) * | 2015-11-19 | 2018-08-28 | 上海现代药物制剂工程研究中心有限公司 | 经鼻给药的流感疫苗免疫制剂及其制备方法 |
| WO2017090766A1 (ja) * | 2015-11-27 | 2017-06-01 | 日東電工株式会社 | 口腔内投与用ワクチン医薬組成物及び口腔内投与用ワクチン医薬組成物の製造方法 |
| KR101944953B1 (ko) * | 2016-07-29 | 2019-02-01 | 메타볼랩(주) | 점막용 항인플루엔자 바이러스 조성물 |
| SG11202002281YA (en) | 2017-10-05 | 2020-04-29 | Toko Yakuhin Kogyo Co Ltd | Nasal hepatitis b vaccine composition and method for producing same |
| JPWO2021002355A1 (ja) | 2019-07-03 | 2021-01-07 | ||
| CN113117093B (zh) * | 2019-12-31 | 2024-02-09 | 辽宁成大生物股份有限公司 | 一种适用于鼻粘膜递送流感疫苗的促进剂 |
| TW202339792A (zh) | 2021-12-02 | 2023-10-16 | 日商東興藥品工業股份有限公司 | 同時以鼻黏膜與鼻咽作為標的部位的經鼻疫苗噴霧用製劑 |
| CN118450903A (zh) * | 2021-12-20 | 2024-08-06 | 东兴药品工业株式会社 | 含有聚丙烯酸系聚合物的疫苗佐剂及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5215739A (en) * | 1989-04-05 | 1993-06-01 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
| US5158761A (en) * | 1989-04-05 | 1992-10-27 | Toko Yakuhin Kogyo Kabushiki Kaisha | Spray gel base and spray gel preparation using thereof |
| JPH0678245B2 (ja) * | 1989-07-04 | 1994-10-05 | 東興薬品工業株式会社 | 鼻腔内噴霧投与用インフルエンザワクチンゲル製剤 |
| CA2601022C (en) | 2005-03-23 | 2023-03-07 | Glaxosmithkline Biologicals S.A. | Use of an influenza virus an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response |
| CA2648553C (en) * | 2006-04-21 | 2015-01-27 | Toko Yakuhin Kogyo Kabushiki Kaisha | Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation |
| JP5072834B2 (ja) | 2006-04-21 | 2012-11-14 | 東興薬品工業株式会社 | 流体用容器およびこれを用いたエアレス式流体投与システム |
| ES2588183T3 (es) * | 2009-03-31 | 2016-10-31 | Japan As Represented By Director-General Of National Institute Of Infectious Diseases | Procedimiento para la prevención de la gripe utilizando una vacuna para administración intranasal |
-
2013
- 2013-10-23 BR BR112015015523-5A patent/BR112015015523B1/pt active IP Right Grant
- 2013-10-23 AU AU2013367751A patent/AU2013367751B2/en active Active
- 2013-10-23 SG SG10201705190TA patent/SG10201705190TA/en unknown
- 2013-10-23 DK DK13867863.6T patent/DK2939692T3/da active
- 2013-10-23 CN CN201380068031.4A patent/CN104884086A/zh active Pending
- 2013-10-23 EP EP19167809.3A patent/EP3566715A1/en not_active Withdrawn
- 2013-10-23 SG SG11201504648TA patent/SG11201504648TA/en unknown
- 2013-10-23 MY MYPI2015701959A patent/MY173503A/en unknown
- 2013-10-23 WO PCT/JP2013/078721 patent/WO2014103488A1/ja active Application Filing
- 2013-10-23 EP EP13867863.6A patent/EP2939692B1/en active Active
- 2013-10-23 SI SI201331485T patent/SI2939692T1/sl unknown
- 2013-10-23 CN CN201910188181.8A patent/CN110038123A/zh active Pending
- 2013-10-23 TR TR2019/10293T patent/TR201910293T4/tr unknown
- 2013-10-23 PT PT13867863T patent/PT2939692T/pt unknown
- 2013-10-23 ES ES13867863T patent/ES2731899T3/es active Active
- 2013-10-23 JP JP2014554202A patent/JP6247639B2/ja active Active
- 2013-10-23 HU HUE13867863 patent/HUE044434T2/hu unknown
- 2013-10-23 RU RU2015130634A patent/RU2652296C2/ru active
- 2013-10-23 PL PL13867863T patent/PL2939692T3/pl unknown
- 2013-10-23 CA CA2894223A patent/CA2894223C/en active Active
- 2013-10-23 NZ NZ70892213A patent/NZ708922A/en unknown
- 2013-10-23 MX MX2015008380A patent/MX371154B/es active IP Right Grant
- 2013-10-23 LT LTEP13867863.6T patent/LT2939692T/lt unknown
- 2013-10-23 US US14/653,131 patent/US20160015800A1/en not_active Abandoned
- 2013-10-23 KR KR1020157016766A patent/KR102071099B1/ko active IP Right Grant
- 2013-10-30 TW TW102139274A patent/TWI624280B/zh active
-
2015
- 2015-06-08 IL IL239284A patent/IL239284B/en active IP Right Grant
- 2015-06-26 PH PH12015501482A patent/PH12015501482A1/en unknown
- 2015-10-28 HK HK15110594.2A patent/HK1209646A1/xx unknown
-
2018
- 2018-11-26 US US16/200,233 patent/US20190091324A1/en not_active Abandoned
-
2019
- 2019-06-28 CY CY20191100681T patent/CY1122372T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1209646A1 (en) | Nasal influenza vaccine composition | |
| HK1207967A1 (en) | Vaccine | |
| EP2758038A4 (en) | NEW INFLUENZA HEMAGGLUTININ PROTEIN VACCINES | |
| HK1212906A1 (zh) | 疫苗組合物 | |
| PL2647387T3 (pl) | Kompozycja szczepionki | |
| EP2806891A4 (en) | PARAIN FLUENZA VIRUS 5 BASED VACCINES | |
| HK1200845A1 (en) | Influenza hemagglutinin variants | |
| EP2876161A4 (en) | VACCINE | |
| GB201223386D0 (en) | Vaccine | |
| EP2852396A4 (en) | INFLUENZA VACCINE CONSTRUCTS | |
| ZA201300395B (en) | Influenza vaccine | |
| ZA201500656B (en) | Marker vaccine | |
| EP2822599A4 (en) | VACCINE | |
| HK1209140A1 (en) | Bovine influenza c virus compositions | |
| HK1201283A1 (en) | Influenza c virus and vaccine | |
| ZA201405107B (en) | Mtb-c vaccine against asthma | |
| HK1200342A1 (zh) | 鼻腔配方 | |
| HK1209647A1 (en) | Dengue virus vaccine composition | |
| GB201202090D0 (en) | Vaccine | |
| SG11201505178VA (en) | Composition for nasal application | |
| DK2846829T3 (en) | Vaccine combinations | |
| GB201217321D0 (en) | Vaccine | |
| GB201210226D0 (en) | Vaccine | |
| GB201206169D0 (en) | Vaccine | |
| GB201205599D0 (en) | Vaccine |